Skip to main content
. 2019 Dec 19;4(24):e126054. doi: 10.1172/jci.insight.126054

Figure 2. IL-7 receptor (IL-7R) engagement by RN168 and phosphorylation of STAT5 in CD3+ T cells.

Figure 2

(A) IL-7R on CD3+ T cells. Baseline mean (±SD) values: placebo 1899.9 (565.6) (n = 7); RN168 1 mg 1327.7 (589.6) (n = 8); RN168 3 mg 1648.3 (376.2) (n = 9); RN168 6 mg 2245.8 (536.5) (n = 5); RN168 8 mg 2185.8 (722.8) (n = 8). (B) pSTAT5 in CD3+ T cells. Baseline mean (±SD) values: placebo 3750.4 (1393.9) (n = 7); RN168 1 mg 3681.7 (1665.7) (n = 8); RN168 3 mg 3707.7 (1321.4) (n = 9); RN168 6 mg 4066.0 (722.0) (n = 5); RN168 8 mg 3877.4 (1065.5) (n = 8).